BRCA1 and Friedreich ataxia: However, it is of note that in both BRCA1 and BRCA2-associated FA-like cases cytotoxic treatment does not always clinically result in excessive toxicity [50,71], and also that malignancies associated with biallelic BRCA2 PGVs do not always appear particularly chemo-sensitive [71].